MedPath

Brain stimulation targeting neurocognition and social functioning in schizophrenia

Not Applicable
Conditions
Health Condition 1: null- schizophrenia
Registration Number
CTRI/2015/01/005448
Lead Sponsor
DEPARTMENT OF BIOTECHNOLOGY MINISTRY OF SCIENCE AND TECHNOLOGY UNDER INCRE FELLOWSHIP
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
45
Inclusion Criteria

1. Diagnosis of Schizophrenia (F20.0-F20.9) according to

ICD-10-DCR

2. Patients on a stable dose of antipsychotic medication

3. Patients of either sex aged between 18-60 years.

4. Right handed, normotensive patients.

5. Patients giving written informed consent.

6. Screened eligible for rTMS.

Exclusion Criteria

1. Current neurological or any comorbid psychiatric disorders.

2. History of substance abuse (Except nicotine and caffeine) in the

past one month.

3. History of epilepsy, significant head injury or any neurosurgical

procedure.

4. Subjects with cardiac pacemakers or other metal parts in the

body.

5. Subjects who have received ECT in past 6 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Working Memory, Emotion Recognition and Social FunctioningTimepoint: Baseline and at the end of 2 weeks of post rTMS intervention
Secondary Outcome Measures
NameTimeMethod
spontaneous gamma oscillatory activity (GOA) and GOA evoked by online working memory and emotion recognition tasks and psychopathology scores PANSSTimepoint: Baseline and at the end of 2 weeks of post rTMS intervention <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath